You are viewing an incomplete version of our website. Please click to reload the website as full version.

Seasonal H1N1 Hemagglutinin antibody

Details for Product No. ABIN500694, Supplier: Log in to see
Avian Influenza Virus H1N1
Enzyme Immunoassay (EIA), Western Blotting (WB)
Log in to see
Supplier Product No.
Log in to see

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen Hemagglutinin antibody was raised against a synthetic peptide from the Hemagglutinin protein. .Remarks: The peptide sequence is unique from the peptide sequence for product AP30771PU-N and AP30772PU-N.
Isotype IgG
Purification Peptide affinity chromatography
Target Type Virus
Background Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States (2). The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic (3). Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin (4). The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups (5). This antibody is specific for the seasonal H1N1 influenza Hemagglutinin and will not recognize the corresponding Hemagglutinin sequence from the swine-origin H1N1 influenza (A/California/14/2009 (H1N1)).Synonyms: Common flu H1, HA, Seasonal Influenza A Hemagglutinin, flu H1
UniProt B0VX44
Application Notes ELISA. Western blot.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Buffer PBS containing 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
Supplier Images
Enzyme Immunoassay (EIA) image for anti-Seasonal H1N1 Hemagglutinin antibody (ABIN500694) ELISA results using Seasonal H1N1 Hemagglutinin antibody at 1 μg/ml and the blocking ...
Enzyme Immunoassay (EIA) image for anti-Seasonal H1N1 Hemagglutinin antibody (ABIN500694) Seasonal Influenza A Hemagglutinin antibody (2 μg/ml) recognizes seasonal influenza A...
Western Blotting (WB) image for anti-Seasonal H1N1 Hemagglutinin antibody (ABIN500694) Western blot analysis of Hemaggutinin using recombinant seasonal Hemagglutinin (lanes...
Product cited in: Morens, Taubenberger, Fauci: "The persistent legacy of the 1918 influenza virus." in: The New England journal of medicine, Vol. 361, Issue 3, pp. 225-9, 2009 (PubMed).

Dawood, Jain, Finelli, Shaw, Lindstrom, Garten, Gubareva, Xu, Bridges, Uyeki: "Emergence of a novel swine-origin influenza A (H1N1) virus in humans." in: The New England journal of medicine, Vol. 360, Issue 25, pp. 2605-15, 2009 (PubMed).

Butler: "Swine flu goes global." in: Nature, Vol. 458, Issue 7242, pp. 1082-3, 2009 (PubMed).

Background publications Thompson, Shay, Weintraub, Brammer, Cox, Anderson, Fukuda: "Mortality associated with influenza and respiratory syncytial virus in the United States." in: JAMA, Vol. 289, Issue 2, pp. 179-86, 2003 (PubMed).